This Combined Synopsis/Solicitation opportunity was posted on January 28, 2010. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Top

65--Automated Allergy Testing System

Awarded

W81K02-10-T-0007Federal

Submission Closed02/01/2010, 05:00:00 AM UTC

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

NAICS: 325413

New

Federal

Blood Type IVD Reagents and Sera SupplyThis subcontract involves the supply of Blood Type IVD Reagents and Sera to prime contractors supporting Department of Veterans Affairs VISN 22 medical supply contracts. The scope of work includes the manufacture or distribution of ABO reverse typing cells, antibody screening cells, and antibody identification cells, as well as the provision of Lewis Blood Group Substance and full antigen profiles. All delivered reagents must be FDA compliant and accompanied by Certificates of Analysis or Conformance. The contract is managed by the Network Contract Office 22 under NAICS code 325413, with a response deadline set for November 16, 2026.

262-NETWORK Contract Office 22 (36C262)

POSTED

DEADLINE

6550--Blood Type IVD Reagents

Solicitation # 36C26227Q0043

The Department of Veterans Affairs, through the Network Contract Office 22, is seeking quotations for solicitation 36C26227Q0043 to establish a Blanket Purchase Agreement for blood type IVD reagents, supplies, and consumables for manual testing at VISN 22 facilities. The contract is structured with a 12-month base ordering period and four subsequent 12-month option periods, for a total potential duration of five years. This is a commercial products and services acquisition under FAR Part 12, with an emphasis on FDA regulatory compliance, potency requirements, and strict cold-chain and temperature-monitoring controls during shipment. All items must be quoted as F.O.B. destination and delivered Monday through Friday between 8am and 4pm. Award will be based on the best value to the government, evaluated through a comparative assessment of technical understanding, price, and quality, regulatory compliance, and product traceability. Technical evaluation considers the offeror's ability to provide a full antigen profile and their procedures for handling nonconforming or defective products. Pricing will be evaluated based on the total cost for the base period and all option periods, including a six-month price addition for the final performance period per FAR 52.217-8. Quotations must be submitted via email to the contract specialist by November 16, 2026, and must include a completed five-year pricing spreadsheet, a past performance questionnaire, and required certifications regarding telecommunications and trade agreements.

262-NETWORK Contract Office 22 (36C262)

POSTED

DEADLINE

Reagents and consumables for Roche immunostainers

Solicitation # 75N98027Q00026

Solicitation 75N98027Q00026 is a Firm-Fixed-Price Indefinite Delivery Indefinite Quantity (IDIQ) contract issued by the National Institutes of Health Office of Logistics and Operations. The objective is to procure proprietary reagents, kits, and consumables compatible with the National Cancer Institute's Roche Ventana Benchmark ULTRA and Benchmark Plus immunostainers. The contract includes a base year starting December 1, 2026, with four subsequent option years, carrying a minimum value of 20,000 dollars and a maximum value of 1.5 million dollars. The scope of work extends beyond supplies to include no-cost software upgrades, VConnect software coverage, and professional consultation from scientists and engineers. The contractor must adhere to strict quality and delivery standards, including overnight shipping using industry-best practices such as dry or wet ice, and ensuring all reagents have expiration dates exceeding 12 months from the shipping date. Deliveries are f.o.b. destination to Bethesda, Maryland, and must typically be completed within five days of a task order. Award will be based on a best value tradeoff evaluation considering technical proposal, equipment capability, delivery, and price. Offerors must provide a Unique Entity Identifier, Taxpayer Identification Number, and business size certification, with responses due by November 16, 2026.

National Institutes Of Health Olao

POSTED

DEADLINE

TEST KIT, CORONAVIRUS D

Solicitation # SPE2DS-27-T-1071

Solicitation SPE2DS-27-T-1071, issued by the DLA Troop Support Medical Supply Chain, is for the procurement of one case of Abbott BinaxNOW COVID-19 Antigen self-test kits for over-the-counter, at-home use. Each case contains 12 kits with 2 tests per kit. The items must be stored between 2-30 degrees Celsius and have a non-extendable shelf life of 12 months, with no more than one month elapsed from the date of manufacture to the date of delivery. Delivery is required within 20 days after receipt of the order, with a final delivery date of October 30, 2026, to the USS IDAHO (SSN 799). The contract mandates strict adherence to Medical Marking Standard No. 1, which supersedes MIL-STD-129, and requires labels to include the contract or lot number and the date of manufacture, expiration, or retest. Packaging must be commercial, utilizing sealed unit containers and suitable exterior shipping containers. Inspection and acceptance will occur at the destination per FAR 52.246-2. Administrative requirements include the use of the Wide Area Workflow system for electronic invoicing and compliance with various FAR and DFARS clauses regarding cybersecurity, the Buy American Act, and the prohibition of covered defense telecommunications equipment. Quotations are due by November 3, 2026.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

CULTURE MEDIUM, THAYER-

Solicitation # SPE2DS-27-T-1066

Solicitation SPE2DS-27-T-1066 is a request for quotations issued by the DLA Troop Support Medical Supply Chain for the procurement of one package of Thayer-Martin Modified (MTM II) Agar culture medium, identified by NSN 6550-01-711-1542. This dark brown, ready-to-use plated medium is specifically designed for the isolation of pathogenic Neisseria from specimens containing mixed flora of bacteria and fungi. The product is delivered in packages of 100 plates and requires strict refrigeration storage between 2 to 8 degrees Celsius (36 to 46 degrees Fahrenheit) and must not be frozen. The contract mandates a non-extendable shelf life of three months, with a requirement that no more than 14 days elapse between the date of manufacture and the date of delivery to the government. Delivery is set for JBER, Alaska, with a required delivery date of October 27, 2026, under FOB Destination terms. Packaging must be commercial and sealed to prevent damage, with marking adhering to Medical Marking Standard No. 1 and shelf-life labels following MMS1C. Administrative requirements include electronic invoicing via the Wide Area WorkFlow system and compliance with various FAR and DFARS clauses, including the Buy American Act, Berry Amendment, and safeguarding of covered defense information. Evaluation will consider technical data for any alternate products offered and may include HUBZone price evaluation preferences. Inspection and acceptance will occur at the destination.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

Supply of ALBAcyte Blood Bank ReagentsThis subcontract involves the manufacture and supply of specialized ALBAcyte blood bank reagents for prime contractors supporting the Department of Veterans Affairs North Texas Health Care System. The scope of work includes the delivery of A1, A2, B, IgG Sensitized, Antibody ID Panels, and C3 Coated RBCs. To ensure product efficacy, the contractor must utilize shipping containers that maintain reagent integrity and adhere to a defined Quality Plan and FDA approval standards. Deliveries are to be made FOB Destination to the Transfusion Medicine Unit located in Dallas, Texas. The contract is categorized under NAICS code 325413 and is managed through the Department of Veterans Affairs Network Contract Office 17.

257-NETWORK Contract Office 17 (36C257)

POSTED

DEADLINE

6550--Blood Bank Reagents

Solicitation # 36C25727Q0065

The Department of Veterans Affairs VA North Texas Health Care System is issuing a Sources Sought Notice to identify qualified vendors capable of providing blood bank reagents for the Transfusion Medicine Unit in Dallas, Texas. These reagents, including ALBAcyte A1, A2, B, IgG Sensitized, Antibody ID Panels, and C3 Coated Red Blood Cells, are essential for manual blood typing and serum antibody detection used in cross-matching blood for transfusions. The anticipated acquisition strategy includes a base year starting May 1, 2027, with four subsequent one-year option periods extending through April 30, 2032. To be considered, vendors must be FDA approved, provide documentation of such approval, and maintain a defined quality plan with adequate supply availability. All shipments must be FOB Destination, and the contractor is responsible for providing appropriate shipping containers. Interested vendors must submit an electronic capability statement in PDF or Word format, including the place of manufacture for all listed reagents, to the designated contract specialist by November 5, 2026, at 9:00 AM CST. This notice is for market research purposes only to determine the appropriate acquisition strategy, such as a small business set-aside, and does not constitute a formal solicitation.

257-NETWORK Contract Office 17 (36C257)

POSTED

DEADLINE

6505--DRESSING, DRAWTEX 4IN X 4IN (VA-27-00014447)

Solicitation # 36C77027Q0015

The Department of Veterans Affairs, National CMOP Office, is conducting market research through a Sources Sought announcement to identify qualified sources for the procurement of Drawtex Dressing, 4in X 4in, packaged as 10ct per box. This action is for market research purposes only and is not a formal solicitation for quotes; therefore, no contract will be awarded based on this specific announcement. The place of performance is located in Ladson, South Carolina, and the primary point of contact is Contract Specialist Claudine Challinor. Interested respondents must submit their information via email by November 3, 2026. Required details include the company's SAM Unique ID Number, business size (Small, Large, SDVOSB, or VOSB), and point of contact information. Specifically, the government is seeking to determine if the respondent is the manufacturer, the manufacturer's product number, and the place of manufacturing. If the respondent is not the manufacturer, they must provide a letter of authorization from the original equipment manufacturer or provide detailed product literature and specifications for alternative products that demonstrate similarities to the Drawtex hydro conductive wound dressing.

National Cmop Office (36C770)

POSTED

DEADLINE

6550--Optilite analyzer reagents

Solicitation # 36C26227Q0052

The Department of Veterans Affairs, Southern Arizona Healthcare System, is soliciting a Firm-Fixed Price Blanket Purchase Agreement under solicitation 36C26227Q0052 for the procurement of FDA-approved reference testing reagents and consumables validated for use on the Optilite analyzer. The scope includes specific items such as Freelite Kappa, Freelite Lambda, and Ceruloplasmin reagents, as well as TENCELL cuvettes and sample cups. To ensure system performance and safety, all materials must be manufactured by Binding Site Laboratories, and substitutions are prohibited. The contract is issued as a full and open competition under NAICS code 325413, with a total estimated period of performance of sixty months, consisting of a base period from November 9, 2026, to November 8, 2027, followed by four one-year option periods. The award will be granted to the responsible offeror whose proposal is most advantageous to the government, based on a technical acceptability review of the Statement of Work and the lowest price. Deliveries are required to be made to various VA Medical Centers across Arizona, California, and New Mexico, with standard orders delivered within four working days of placement. All shipments must be destination-based, with the vendor assuming all shipping costs and adhering to strict packaging standards to prevent damage. Invoicing is handled electronically through the Department of Veterans Affairs Financial Services Center in accordance with the Prompt Payment Act. Quotes must be submitted via email to Contract Specialist Carlos Magana by November 4, 2026.

262-NETWORK Contract Office 22 (36C262)

POSTED

DEADLINE

Supply of i-STAT PT Plus Control Reagent Level 1This subcontract involves the procurement and delivery of i-STAT PT Plus Control Reagent Level 1 for coagulation testing to support prime contractors fulfilling Department of Defense supply contracts. The scope of work requires the delivery of two boxes, each containing ten 1.0 mL units, shipped FOB Destination to a performance location in APO 96260-5479. To ensure quality and safety, all supplied reagents must adhere to Regulation 864.7750 Class II requirements and maintain full compliance with Registration, Listing, Labeling, and Good Manufacturing Practices. This requirement is managed under NAICS code 325413 for the Medical Supply Chain MD Surg FSF agency.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

CONTROL SET, BLOOD CHEM

Solicitation # SPE2DS-27-T-0906

Solicitation SPE2DS-27-T-0906 is a request for quotations from DLA Troop Support for two sets of DXH 500 Series Blood Chemistry Control (NSN 6550-01-688-9090). This assayed whole blood control is used to monitor multi-parameter hematology cell counters and includes abnormal low, normal, and abnormal high components. The items must be stored refrigerated and upright between 2 to 8 degrees Celsius and protected from freezing and overheating. Delivery is required within 20 days after receipt of order, with a required delivery date of October 27, 2026, under FOB Destination terms. The contract imposes strict shelf-life requirements, specifying a non-extendable shelf life of 3 months, with no more than 13 days elapsed from the date of manufacture to the date of delivery. Packaging must be commercial and compliant with RP001 and MIL-STD-2073-1E, while marking must adhere to Medical Marking Standard No. 1. Invoicing is to be processed electronically via the Wide Area Workflow system. This is not a small business set-aside, and the procurement falls under NAICS code 325413. Compliance with the Buy American and Balance of Payments Program and DFARS safeguarding of covered defense information is required.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

CONTROL, BLOOD CHEMISTR

Solicitation # SPE2DS-27-T-0950

Solicitation SPE2DS-27-T-0950 is a Request for Quotations issued by the Department of Defense, DLA Troop Support Medical Supply Chain, for the procurement of two boxes of i-STAT PT Plus Control Reagent Level 1 (NSN 6550-01-728-5703). This reagent is used for coagulation testing and is compatible with the i-STAT PT Plus cartridge and the i-STAT 1 Government Field Kit analyzer. Each box contains ten 1.0 mL units. The required delivery date is October 23, 2026, with a delivery window of 83 days after award. Inspection and acceptance will occur at the destination per FAR 52.246-2. The contract mandates strict quality and storage requirements, including refrigeration between 2 to 8 degrees Celsius and a non-extendable shelf life of 12 months. Items must be delivered within one month of the manufacture date. Packaging must be commercial and adhere to MIL-STD-2073-1E and RP001, with marking compliant with Medical Marking Standard No. 1. Labels must include the contract/lot number and manufacture or expiration dates. The procurement is not a small business set-aside, though a HUBZone price evaluation preference may be applied. Compliance with the Buy American Act and DFARS domestic material restrictions is required, and electronic invoicing must be processed through the Wide Area WorkFlow system.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

5 days ago

DEADLINE

in 3 days

AI Contract Overview

The US Army Medical Command, Pacific Regional Contracting Office at Tripler Army Medical Center in Hawaii is seeking a provider for an automated allergy testing system. The requirement includes the lease of an ImmunoCap 250 analyzer along with all necessary reagents, training, and maintenance. The scope of the purchase covers a wide array of specific and total Ige conjugates, calibrator strips, control strips, and various routine, esoteric, and recombinant allergens, as well as essential washing and development solutions. The government intends to issue a sole source award to Phadia USA Inc. because the equipment and reagents must be FDA approved and compatible with existing usage at other Army Military Training Facilities. The procurement is categorized under NAICS code 325413 and is designated as a Total Small Business Set-Aside. While the intent is a sole source award, other capable firms may submit a narrative statement of capability and itemized pricing for consideration within the specified response window.

General Info

Agency

N/A

Contract Value

$195,159.56

NAICS

325413 - In-Vitro Diagnostic Substance Manufacturing

Place of Performance

Pacific Regional Contr Ofc TAMC ATTN: MCAA PC BLDG 160, 160 Krukowski Road Honolulu HI 96859-5000 US, MI, USA

Set-Aside

SBA

Awardee

PHADIA US INC

Award Issued Date

07/19/2010, 12:00:00 AM UTC

Documents

No documents available

Documents will appear here when they are available.

AI Contract Breakdown

Uniform Contract Format

No documents to break down

The breakdown needs solicitation documents. None were found from this contract's source.

Timeline

PhaseAwarded

PostedJan 28

Combined Synopsis

AwardedJul 19

Contract was awarded

Submission Closed

02/01/2010, 05:00:00 AM UTC

Find active opportunities like this

Get full access to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

AgencyN/A

ContactsNo contacts available

OfficeN/A

Organization / Agency

N/A

Office AddressN/A

ContactsNo contact information available

Full Description

This is a combined synopsis/solicitation for commercial items prepared in accordance with the format in Subpart 12.6, as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; proposals are being requested and a written solicitation will not be issued. The US Army Medical Command, Pacific Regional Contracting Office (PRCO), Tripler Army Medical Center, Hawaii intends to issue a sole source award to Phadia USA Inc., 4169 Commercial Ave., Portage, MI 49002-9701. This purchase includes: Lease of contractor owned allergy testing analyzer, ImmunoCap 250, to include equipment, reagents, training and maintenance necessary to perform automated allergy testing. Also includes the following: Immunocap Specific Ige Conjugate, Product # 10-9316-02, 41AF; Specific Ige, Anti-Ige ImmunoCap Carrier, Product # 14-4417-01, 41SI; ImmunoCap Specific Ige Calibrator Strip 0-100, Product # 10-9459-01, 41AS; ImmunoCap Specific Ige Curve Control Strip, Product # 10-9312-01, 41BX; ImmunoCap Specific Ige Control, Product # 10-9449-01, 41BX; : ImmunoCap Specific Ige Negative Control, Product # 10-9445-01, 41BX; Routine Allergen, 53GX; Esoteric Allergen, 53FX; Esoteric Allergen, 54DY; Esoteric Allergen, 54DX; Esoteric Allergen, 53EY; Esoteric Allergen, 53EX; Optimized Allergen, 53HX; Esoteric Allergen, 56XX; Recombinant Allergen, 57XX; ImmunoCap Total Ige Conjugate, Product # 10-9319-01, 41SF; ImmunoCap Total Ige Anti-Ige ImmunoCap, Product #14-4509-01, 41SI; ImmunoCap Total Ige Calibrator Strip, Product # 10-9387-01, 41SS; ImmunoCap Total Ige Curve Control Strip, Product # 10-9325-01, 41BX; Immunocap Total Ige Control (lmh), Product #10-9447-01, 41BX; ImmunoCap Development Solution, Product #10-9441-01, 41AD; ImmunoCap Stop Solution, Product #10-9442-01, 41AD; Washing Solution, Product #10-9202-01, 53KX; ImmunoCap Ige/Ecp/Tryptase Sample Diluent, Product # 10-9360-01; 53BS; ImmunoCap Specific Iga/Igg Sample Diluent, Product #10-9361-01; 53BS; ImmunoCap Fluoro C, Product #10-9264-01, 41FC; Esoteric Allergen, 53G; Shipping and handling, Routine Allergens, 53FR; Optimized Allergen, 53GO; Esoteric Allergen, 53DY; Routine Allergen, 54DR; Maintenance Solution, Product # 10-9476-01; 41AE. Salient Characteristics are: Analyzer and reagents must be FDA approved; analyzer and reagents must be compatible with existing usage at other Army Military Training Facilites (MTF); analyzer and reagents are physician recommended due to user(s) familiarity, training, experience and confidence of equipment. The NAICS Code/Size is 325413/500EM. The following clauses and addendum are incorporated and are to remain in full force in any resultant contract: FAR 52.212-4 [Contract Terms and Conditions Commercial Items]. FAR 52.212-4 Addendum. The following addition/changes are made to FAR Clause 52.212-4, which is incorporated by reference: The following clause(s) is/are hereby incorporated by reference: FAR 52.202-1 [Definitions], FAR 52.203-3 [Gratuities], 52.203-6 [Restrictions On Subcontractor Sales To The Government], 52.203-12 [Limitations on Payments To Influence Certain Federal Transaction], 52.204-4 [Printed or Copied Double-Sided on Recycled Paper], 52.209-6 [Protecting the Governments Interest When Subcontracting With Contractors Debarred, Suspended, or Proposed for Debarment], 52.219-6, [Notice of Total Small Business Set-Aside], 52.219-14 [Limitations on Subcontracting], 52.219-28 [Post-Award Small Business Program Representation], 52.222-3 [Convict Labor], 52.222-19 [Child Labor-Cooperation w/Authorities and Remedies], 52.222-21 [Prohibition Of Segregated Facilities], 52.222-26 [Equal Opportunity}, 52.222-35 [Equal Opportunity For Special Disabled Veterans, Veterans of the Vietnam Era, and Other Eligible Veterans], 52.222-36 [Affirmative Action For Workers With Disabilities], 52.222-37 [Employment Reports On Special Disabled Veterans, Veterans of the Vietnam Era, and Other Eligible Veterans], 52.222-39 [Notification of Employee Rights Concerning Payment of Union Dues or Fees], 52.222-50 [Combatting Trafficking In Persons}, 52.225-13 [Restrictions on Certain Foreign Purchases], 52.232-17 [Interest], 52.232-23 [Assignment of Claims], 52.232-33 [Payment by Electronic Funds TransferCentral Contractor Registration], 52.233-3 [Protest After Award], 52.233-4 [Applicable Law for Breach of Contract Claim], 52.242-13 [Bankruptcy], 52.247-34 [F.O.B. Destination], 252.209-7004 [Subcontracting With Firms That Are Owned or Controlled By The Government of a Terrrorist Country], 252.223-7006 [Prohibition on Storage and Disposal of Toxic and Hazardous Materials], 252.225-7001 [Buy America Act and Balance of Payments Program], 252.232-7003 [Electronic Submission of Payment Requests and Receiving Reports], 252.232-7010 [Levies on Contract Payments], 252.243-7002 [Requests for Equitable Adjustment]. The following clause(s) is/are hereby incorporated by full text: 52.217-9 [Option to Extend the Term of the Contract], 52.252-2 [Clauses Incorporated by Reference], 252.212-7001 [Contract Terms and Conditions Required to Implement Statutes or Executive Orders Applicable to Defense Acquisitions of Commercial Items (Deviation)], 252.243-7001 [Pricing of Contract Modifications], H, W and 52.212-5 [Contract Terms and Conditions Required to Implement Statutes or Executive Orders Applicable to Defense Acquisitions of Commercial Items (Deviation)]. Any firm believing itself capable of providing this system may respond by submitting a written narrative statement of capability within two (2) days of date of notice to Susan Martinez at contact@example.gov for consideration by the agency. Response must include detailed technical information and other technical literature demonstrating the ability to meet these requirements. Responses shall also include itemized pricing that is sufficient to make a determination that competition is feasible. No telephone or facsimile requests will be accepted. If no affirmative responses are received to determine whether a qualified source is more advantageous to the Government, an order will be placed with Phadia US, Inc. Responses received will be evaluated; however, a determination by the Government not to compete the proposed procurement based upon responses to this notice is solely within the descretion of the Government. If no responses are received, PRCO will proceed with the sole source purchase order.